[Federal Register Volume 68, Number 116 (Tuesday, June 17, 2003)]
[Notices]
[Pages 35915-35916]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-15197]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 5, 2003, and published in the Federal 
Register on February 12, 2003, (68 FR 7147), Cedarburg Pharmaceuticals, 
LLS 870 Badger Circle, Grafton, Wisconsin 53024, made application by 
renewal to the Drug Enforcement Administration to be registered as a 
bulk manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances for 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Cedarburg Pharmaceuticals, LLC, to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Cedarburg 
Pharmaceuticals, LLC, to ensure that the company's registration is 
consistent with the public interest. This investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic classes of controlled substances listed above 
is granted.


[[Page 35916]]


    Dated: June 4, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-15197 Filed 6-16-03; 8:45 am]
BILLING CODE 4410-09-M